Johann E Gudjonsson MD PhD
1 clinical trials · Sponsor
◉ Watch Johann E Gudjonsson MD PhD
| Record | Firm | Date |
|---|---|---|
| Lebrikizumab in Moderate-to-severe Atopic Dermatitis (NCT06906497) | Johann E Gudjonsson MD PhD | 2025-07-02 |
Track Johann E Gudjonsson MD PhD automatically
Every clearance here is in the API, with alerts when new ones post.